Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions.
Immunogenetics of multiple sclerosis: more questions than answers.
Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.
Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific.
Gamified Design for Health Workshop.
Erythropoietin reduces white matter damage in two-day-old rats exposed to hypoxic/ischemia injury.
A Systematic Review of Health-related Work Outcome Measures, and Quality Criteria based Evaluations of their Psychometric Properties.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Multiple sclerosis : understanding a complex neurological condition.
N-Truncated Aβ 2-X Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models.
Switching or Discontinuing Disease-Modifying Therapies for Multiple Sclerosis.
The role of psychological well-being in Multiple Sclerosis rehabilitation.
Physical activity and the incidence of multiple sclerosis.
Changes in Multidigit Synergies and Their Feed-Forward Adjustments in Multiple Sclerosis.
[Guidelines for vaccination of immunocompromised individuals].
Author Response.
Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study.
The obesity-related pathology and Th17 cells.
Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its Improvement.
Mesoscopic Model of Neuronal System Deficits in Multiple Sclerosis.
Oligodendroglial deletion of ESCRT-I component TSG101 causes spongiform encephalopathy.
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.
Pages
« first
‹ previous
…
728
729
730
731
732
733
734
735
736
…
next ›
last »